NCAM1 and leukoencephalopathy with calcifications and cysts: These findings are consistent with previous reports suggesting that neuroendocrine differentiation—identified by the presence of markers such as chromogranin A, synaptophysin, and CD56—is associated with unfavorable outcomes in LCC.